1. Home
  2. TIVC vs BDRX Comparison

TIVC vs BDRX Comparison

Compare TIVC & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tivic Health Systems Inc.

TIVC

Tivic Health Systems Inc.

N/A

Current Price

$1.96

Market Cap

3.6M

Sector

Health Care

ML Signal

N/A

Logo Biodexa Pharmaceuticals plc

BDRX

Biodexa Pharmaceuticals plc

N/A

Current Price

$5.45

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TIVC
BDRX
Founded
2016
2000
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
4.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TIVC
BDRX
Price
$1.96
$5.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
60.0K
2.5M
Earning Date
11-14-2025
09-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$482,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.47
$3.58
52 Week High
$15.64
$92.00

Technical Indicators

Market Signals
Indicator
TIVC
BDRX
Relative Strength Index (RSI) 44.24 50.55
Support Level $1.97 $4.55
Resistance Level $2.70 $7.22
Average True Range (ATR) 0.19 1.47
MACD 0.03 0.11
Stochastic Oscillator 19.39 31.98

Price Performance

Historical Comparison
TIVC
BDRX

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: